Literature DB >> 20308612

Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis.

Daichi Shimbo1, Paul Muntner, Devin Mann, Anthony J Viera, Shunichi Homma, Joseph F Polak, R Graham Barr, David Herrington, Steven Shea.   

Abstract

Hypertension is associated with impaired endothelial function in cross-sectional studies. However, few longitudinal data exist on whether endothelial dysfunction precedes the development of hypertension. We examined the cross-sectional and longitudinal relationships between endothelial-dependent brachial artery flow-mediated dilation (FMD) and hypertension prevalence and incidence in 3500 participants from the Multi-Ethnic Study of Atherosclerosis, an ethnically diverse, community-based cohort study. At baseline, the prevalence ratios (95% CI) of hypertension from the highest to the lowest quartile of FMD were 1.00 (referent), 1.26 (1.12 to 1.40), 1.35 (1.21 to 1.52), and 1.68 (1.50 to 1.87; linear trend P<0.001). This association remained (P=0.017) after adjustment for demographics (age, sex, and ethnicity), Multi-Ethnic Study of Atherosclerosis site, and other risk factors. Of the 1869 participants without hypertension at baseline, 584 (31.3%) developed hypertension over a median follow-up of 4.8 years. The unadjusted relative risks (95% CI) of incident hypertension from the highest to the lowest quartile of FMD were 1.00 (referent), 1.38 (1.14 to 1.67), 1.44 (1.19 to 1.74), and 1.64 (1.36 to 1.97; linear trend P<0.001). However, after adjustment for demographics and Multi-Ethnic Study of Atherosclerosis site, the relationship between FMD and incident hypertension was attenuated and not statistically significant: 1.00 (referent), 1.26 (1.04 to 1.52), 1.19 (0.98 to 1.44), and 1.18 (0.97 to 1.44). The longitudinal results also did not appreciably change after adjustment for additional risk factors and baseline blood pressure levels. In this sample, reduced FMD was not an independent predictor of hypertension incidence, suggesting that impaired endothelial function does not play a major role in the development of hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308612      PMCID: PMC2896877          DOI: 10.1161/HYPERTENSIONAHA.109.143123

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  26 in total

1.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.

Authors:  Mary C Corretti; Todd J Anderson; Emelia J Benjamin; David Celermajer; Francois Charbonneau; Mark A Creager; John Deanfield; Helmut Drexler; Marie Gerhard-Herman; David Herrington; Patrick Vallance; Joseph Vita; Robert Vogel
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

2.  Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study.

Authors:  Joseph Yeboah; John R Crouse; Fang-Chi Hsu; Gregory L Burke; David M Herrington
Journal:  Circulation       Date:  2007-04-23       Impact factor: 29.690

Review 3.  Endothelial dysfunction associated with oxidative stress in human.

Authors:  H Matsuoka
Journal:  Diabetes Res Clin Pract       Date:  2001-12       Impact factor: 5.602

4.  Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Authors:  Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

5.  Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study.

Authors:  Noyan Gokce; John F Keaney; Liza M Hunter; Michael T Watkins; James O Menzoian; Joseph A Vita
Journal:  Circulation       Date:  2002-04-02       Impact factor: 29.690

6.  Brachial flow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter.

Authors:  D M Herrington; L Fan; M Drum; W A Riley; B E Pusser; J R Crouse; G L Burke; M A McBurnie; T M Morgan; M A Espeland
Journal:  J Cardiovasc Risk       Date:  2001-10

Review 7.  Essential hypertension.

Authors:  Franz H Messerli; Bryan Williams; Eberhard Ritz
Journal:  Lancet       Date:  2007-08-18       Impact factor: 79.321

8.  A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study.

Authors:  Nisha I Parikh; Michael J Pencina; Thomas J Wang; Emelia J Benjamin; Katherine J Lanier; Daniel Levy; Ralph B D'Agostino; William B Kannel; Ramachandran S Vasan
Journal:  Ann Intern Med       Date:  2008-01-15       Impact factor: 25.391

9.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

10.  Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction.

Authors:  Sharon M L Wallace; Carmel M McEniery; Kaisa M Mäki-Petäjä; Anthony D Booth; John R Cockcroft; Ian B Wilkinson
Journal:  Hypertension       Date:  2007-05-14       Impact factor: 10.190

View more
  31 in total

1.  Brachial artery diameter and the right ventricle: the Multi-Ethnic Study of Atherosclerosis-right ventricle study.

Authors:  Christopher T Dibble; Daichi Shimbo; R Graham Barr; Emilia Bagiella; Harjit Chahal; Corey E Ventetuolo; David M Herrington; Joao A C Lima; David A Bluemke; Steven M Kawut
Journal:  Chest       Date:  2012-12       Impact factor: 9.410

2.  Association of left ventricular hypertrophy with incident hypertension: the multi-ethnic study of atherosclerosis.

Authors:  Daichi Shimbo; Paul Muntner; Devin Mann; R Graham Barr; Weihong Tang; Wendy Post; Joao Lima; Gregory Burke; David Bluemke; Steven Shea
Journal:  Am J Epidemiol       Date:  2011-03-21       Impact factor: 4.897

Review 3.  Biomechanical regulation of vascular smooth muscle cell functions: from in vitro to in vivo understanding.

Authors:  Juhui Qiu; Yiming Zheng; Jianjun Hu; Donghua Liao; Hans Gregersen; Xiaoyan Deng; Yubo Fan; Guixue Wang
Journal:  J R Soc Interface       Date:  2013-10-23       Impact factor: 4.118

Review 4.  Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.

Authors:  Rikki M Tanner; David A Calhoun; Emmy K Bell; C Barrett Bowling; Orlando M Gutiérrez; Marguerite R Irvin; Daniel T Lackland; Suzanne Oparil; William McClellan; David G Warnock; Paul Muntner
Journal:  Am J Kidney Dis       Date:  2014-01-01       Impact factor: 8.860

5.  Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia.

Authors:  J Liu; Y Xu; H Zhang; X Gao; H Fan; G Wang
Journal:  J Hum Hypertens       Date:  2014-03-27       Impact factor: 3.012

6.  Invited Commentary: Hypertension and Arterial Stiffness--Origins Remain a Dilemma.

Authors:  David R Jacobs; Daniel A Duprez; Daichi Shimbo
Journal:  Am J Epidemiol       Date:  2016-03-08       Impact factor: 4.897

Review 7.  Vascular endothelial function and hypertension: insights and directions.

Authors:  Kodlipet Dharmashankar; Michael E Widlansky
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

8.  Short-term regular aerobic exercise reduces oxidative stress produced by acute in the adipose microvasculature.

Authors:  Austin T Robinson; Ibra S Fancher; Varadarajan Sudhahar; Jing Tan Bian; Marc D Cook; Abeer M Mahmoud; Mohamed M Ali; Masuko Ushio-Fukai; Michael D Brown; Tohru Fukai; Shane A Phillips
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-02-24       Impact factor: 4.733

9.  AHA/ACC-defined stage 1 hypertensive adults do not display cutaneous microvascular endothelial dysfunction.

Authors:  Gabrielle A Dillon; Jody L Greaney; Sean Shank; Urs A Leuenberger; Lacy M Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-07-31       Impact factor: 4.733

10.  Prevalence of apparent treatment-resistant hypertension among individuals with CKD.

Authors:  Rikki M Tanner; David A Calhoun; Emmy K Bell; C Barrett Bowling; Orlando M Gutiérrez; Marguerite R Irvin; Daniel T Lackland; Suzanne Oparil; David Warnock; Paul Muntner
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-18       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.